IGIIX
Price
$39.10
Change
-$0.75 (-1.88%)
Updated
Feb 21 closing price
Net Assets
915.57M
RNPHX
Price
$64.29
Change
-$0.79 (-1.21%)
Updated
Feb 21 closing price
Net Assets
147.51B
Ad is loading...

IGIIX vs RNPHX

Header iconIGIIX vs RNPHX Comparison
Open Charts IGIIX vs RNPHXBanner chart's image
Macquarie Global Growth Fund
Price$39.10
Change-$0.75 (-1.88%)
VolumeN/A
Net Assets915.57M
American Funds New Perspective R5E
Price$64.29
Change-$0.79 (-1.21%)
VolumeN/A
Net Assets147.51B
IGIIX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IGIIX vs. RNPHX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGIIX is a Buy and RNPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 148B vs. IGIIX (916M). RNPHX pays higher dividends than IGIIX: RNPHX (1.00) vs IGIIX (0.61). IGIIX was incepted earlier than RNPHX: IGIIX (18 years) vs RNPHX (9 years). IGIIX is a more actively managed with annual turnover of: 39.00 vs. RNPHX (17.00). IGIIX has a lower initial minimum investment than RNPHX: IGIIX (0) vs RNPHX (250). RNPHX (10.58) and IGIIX (10.08) have marching annual gain over last year. RNPHX return over 5 years is better than : 34.72 vs. IGIIX (-20.95).
IGIIXRNPHXIGIIX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years9 years-
Gain YTD4.7704.639103%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets916M148B1%
Annual Yield % from dividends0.611.0061%
Returns for 1 year10.0810.5895%
Returns for 3 years-29.6914.84-200%
Returns for 5 years-20.9534.72-60%
Returns for 10 years-7.95N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO7.960.08
+1.02%
Gogo
PUK17.99-0.18
-0.99%
Prudential PLC
ABTS0.41-0.01
-2.14%
Abits Group
RARE42.59-1.89
-4.25%
Ultragenyx Pharmaceutical
SMID34.74-2.37
-6.39%
Smith-Midland Corp